C
sarcoidosis
Comorbid ConditionsDisease / conditionrisknon modifiable
8
evidence score
PREVENT status
Not a PREVENT input variable.
Causal support
observational only
Score components
lit volume: 3meta-analyses: 0trials: 4.8genetic: 0MR bonus:
References (1)
0 meta-analyses / systematic reviews- Atherosclerotic Vessel Changes in Sarcoidosis. — Advances in experimental medicine and biology 2016 · PMID 26820732
Clinical trials (2)
| NCT | Title | Status | Type | Interventions |
|---|---|---|---|---|
| NCT04758650 | Phase II Study to Evaluate the Clinical Potential of 68GaNOTA-Anti-MMR-VHH2 for in Vivo Imaging of MMR-expressing Macrophages by Means of Positron Emission Tomography (PET) in Oncological Lesions,Cardiovascular Atherosclerosis,Syndrome With Abnormal Immune Activation and sarcoïdosis | TERMINATED | INTERVENTIONAL | 68GaNOTA-Anti-MMR-VHH2 |
| NCT02888080 | A Multiple-dose, Subject and Investigator Blinded, Placebo-controlled, Parallel Design Study to Assess the Efficacy, Safety and Tolerability of ACZ885(Canakinumab) in Patients With Pulmonary Sarcoidosis | COMPLETED | INTERVENTIONAL | ACZ885, Placebo |
Genetic associations (0)
None linked.